QuidelOrtho To Participate In Upcoming Investor Conferences
Upcoming Investor Conferences: QuidelOrtho Corporation will participate in the Evercore ISI 8th Annual Healthcare Conference on December 2, 2025, and the Citi Global Healthcare Conference on December 3, 2025, with management team fireside chats scheduled for both events.
Access to Webcasts: Interested parties can access live webcasts and replays of the conferences through the "Events & Presentations" section on QuidelOrtho's Investor Relations website.
Company Overview: QuidelOrtho is a leading global provider of diagnostic solutions, specializing in various testing methods to improve patient outcomes and healthcare decisions.
Contact Information: For investor inquiries, Juliet Cunningham is the Vice President of Investor Relations, and for media inquiries, D. Nikki Wheeler is the Senior Director of Corporate Communications.
Discover Tomorrow's Bullish Stocks Today
Analyst Views on QDEL
About QDEL
About the author

QuidelOrtho Releases Podcast Episode on Blood Supply Challenges
- Blood Supply Pressures: Michelle Mullens from QuidelOrtho highlights in the podcast that the modern blood supply faces pressures from climate change and persistent demand, emphasizing the importance of stable donations for healthcare safety.
- Donor Engagement: Mullens stresses that consistent donor engagement is crucial for maintaining continuity in healthcare, particularly in today's complex clinical practice environment.
- Ecosystem Connectivity: The podcast explores the interconnectedness of donors, diagnostics, and patient care, revealing how effective communication and engagement can enhance the stability of the blood supply chain.
- Diagnostic Solutions: QuidelOrtho is dedicated to providing fast, accurate, and reliable diagnostic solutions to improve patient outcomes, showcasing the company's expertise and innovation in the field of blood testing.

QuidelOrtho Releases Podcast Episode on Blood Supply Challenges
- Blood Supply Pressure: Climate change and routine trauma events create unpredictable demand for blood products, forcing healthcare institutions to face greater challenges in blood supply chain management, which impacts patient treatment outcomes.
- Rising Demand for O-Type Blood: The growth of low-titer whole blood programs accelerates the consumption of O-type units, necessitating more targeted donor recruitment and precise inventory management to meet the increasing clinical needs.
- Automation Enhances Resilience: Standardized, high-throughput immunohematology platforms improve safety and ensure operational continuity during surges, allowing staff to focus on complex cases, thereby enhancing overall healthcare service quality.
- Importance of Donors: Every blood type plays a crucial role in supporting direct transfusion needs and the diagnostic reagents necessary for safe transfusions, emphasizing the importance of consistent year-round donations to maintain safety across the healthcare system.






